These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 25903419

  • 1. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients.
    Cerda A, Rodrigues AC, Alves C, Genvigir FD, Fajardo CM, Dorea EL, Gusukuma MC, Pinto GA, Hirata MH, Hirata RD.
    Cardiovasc Ther; 2015 Aug; 33(4):168-76. PubMed ID: 25903419
    [Abstract] [Full Text] [Related]

  • 2. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia.
    Hernandez-Mijares A, Bañuls C, Rovira-Llopis S, Diaz-Morales N, Escribano-Lopez I, de Pablo C, Alvarez A, Veses S, Rocha M, Victor VM.
    Atherosclerosis; 2016 Apr; 247():40-7. PubMed ID: 26868507
    [Abstract] [Full Text] [Related]

  • 3. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.
    Genvigir FD, Rodrigues AC, Cerda A, Arazi SS, Willrich MA, Oliveira R, Hirata MH, Dorea EL, Bernik MM, Curi R, Hirata RD.
    Pharmacogenomics; 2010 Sep; 11(9):1235-46. PubMed ID: 20860464
    [Abstract] [Full Text] [Related]

  • 4. Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe.
    Rudofsky G, Reismann P, Groener JB, Djuric Z, Fleming T, Metzner C, Grafe IA, Bierhaus A, Nawroth PP.
    Atherosclerosis; 2012 Jul; 223(1):190-6. PubMed ID: 22633472
    [Abstract] [Full Text] [Related]

  • 5. The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
    Efrati S, Averbukh M, Dishy V, Faygenzo M, Friedensohn L, Golik A.
    Eur J Clin Pharmacol; 2007 Feb; 63(2):113-21. PubMed ID: 17200833
    [Abstract] [Full Text] [Related]

  • 6. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 7. Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.
    Geiss HC, Otto C, Hund-Wissner E, Parhofer KG.
    Atherosclerosis; 2005 May; 180(1):107-12. PubMed ID: 15823282
    [Abstract] [Full Text] [Related]

  • 8. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM, Tipping D, Polis AB, Tomassini JE, Tershakovec AM.
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [Abstract] [Full Text] [Related]

  • 9. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 10. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 11. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1035-42. PubMed ID: 17349882
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
    Li L, Zhang M, Su F, Li Y, Shen Y, Shen J, Zhang D.
    Lipids Health Dis; 2015 Feb 18; 14():10. PubMed ID: 25879728
    [Abstract] [Full Text] [Related]

  • 13. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
    Pesaro AE, Serrano CV, Katz M, Marti L, Fernandes JL, Parra PR, Campos AH.
    J Cardiovasc Pharmacol Ther; 2013 Sep 18; 18(5):447-52. PubMed ID: 23739650
    [Abstract] [Full Text] [Related]

  • 14. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.
    Guimarães ES, Cerda A, Dorea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC.
    Cardiovasc Ther; 2017 Dec 18; 35(6):. PubMed ID: 28940978
    [Abstract] [Full Text] [Related]

  • 15. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM.
    J Clin Lipidol; 2011 Dec 18; 5(6):474-82. PubMed ID: 22108151
    [Abstract] [Full Text] [Related]

  • 16. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression.
    Cerda Á, Genvigir FD, Rodrigues AC, Willrich MA, Dorea EL, Bernik MM, Arazi SS, Oliveira Rd, Hirata MH, Hirata RD.
    J Atheroscler Thromb; 2011 Dec 18; 18(8):640-51. PubMed ID: 21512283
    [Abstract] [Full Text] [Related]

  • 17. Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients.
    Descamps O, Tomassini JE, Lin J, Polis AB, Shah A, Brudi P, Hanson ME, Tershakovec AM.
    Atherosclerosis; 2015 Jun 18; 240(2):482-9. PubMed ID: 25913444
    [Abstract] [Full Text] [Related]

  • 18. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL, Batista MC, Ferreira SR.
    Metabolism; 2010 Jun 18; 59(6):921-6. PubMed ID: 20199786
    [Abstract] [Full Text] [Related]

  • 19. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM, Abate N, Yuan Z, King TR, Palmisano J.
    Am Heart J; 2005 Mar 18; 149(3):464-73. PubMed ID: 15864235
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM, Brown WV, Zieve F, Adewale AJ, Flaim D, Lowe RS, Jones-Burton C, Tershakovec AM.
    Am J Cardiol; 2010 Nov 01; 106(9):1255-63. PubMed ID: 21029821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.